Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory review

Circ Cardiovasc Interv. 2009 Dec;2(6):574-9. doi: 10.1161/CIRCINTERVENTIONS.109.871996.

Authors

David E Kandzari¹, Andrew Farb, Ashley B Boam

Affiliation

¹ Division of Cardiovascular Disease, Scripps Clinic, Maildrop S1056, 10666 North Torrey Pines Rd, La Jolla, CA 92037, USA. [email protected]

PMID: 20031776
DOI: 10.1161/CIRCINTERVENTIONS.109.871996

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Angioplasty, Balloon, Coronary / adverse effects
Angioplasty, Balloon, Coronary / instrumentation*
Angioplasty, Balloon, Coronary / legislation & jurisprudence*
Clinical Trials as Topic
Coronary Artery Disease / therapy*
Device Approval / legislation & jurisprudence*
Drug-Eluting Stents*
Endpoint Determination
Evidence-Based Medicine
Government Regulation*
Guideline Adherence
Health Policy*
Humans
Platelet Aggregation Inhibitors / therapeutic use
Practice Guidelines as Topic
Risk Assessment
Thrombosis / etiology
Thrombosis / prevention & control
Treatment Outcome
United States
United States Food and Drug Administration / legislation & jurisprudence*

Substances

Platelet Aggregation Inhibitors